Jalal Jalaly, MD

Pathology and Laboratory Medicine
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Call 800-789-7366
Penn Medicine Provider

About me

  • Associate Professor of Clinical Pathology and Laboratory Medicine

My education and training

  • Medical School: King Saud University
  • Residency: Barnes-Jewish Hospital - Washington University, St. Louis
  • Fellowship: Barnes-Jewish Hospital - Washington University, St. Louis
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Jalaly is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Vikram Vasan, Lovely Raghav, Malay Sannigrahi, Robert Brody, Alexander Lin, John Nicholas Lukens, Lova Sun, Iain M Morgan, Ahmed Diab, Jalal Jalaly, Devraj Basu Defining the clinical and biologic implications of HPV genome state variability among oropharyngeal cancers using transcriptomic analysis , ASCO: 2026

Sujani Madabhushi ∙ Jalal Jalaly ∙ Salvatore Priore ∙ Portia Kreiger Calcifying Nested Stromal-Epithelial Tumor of the Liver: A Pilot Study Using Next Generation Sequencing of Microdissected Stromal and Epithelial Components , USCAP: 2026

Basu D, Sannigrahi MK, Raghav L, Rajagopalan P, Brody R, Jalaly J, Gallant JN Evidence of a role for oropharyngeal cancer cells with low HPV gene expression in treatment failure , Journal of Clinical Oncology (ASCO): 2025

Hieromnimon HM, Trzcinska A, Wen F, Howard FM, Dolezal JM, Dyer E, Kochanny S, Schulte J, Wang C, Chen H, Chin J, …, Jalaly JB, et al Interpretable HPV detection in head and neck cancer using foundation models and synthetic digital pathology , Cancer Research: 2025

Sannigrahi MK, Raghav L, Rich DJ, Schrank TP, Califano JA, Lukens JN, Sun L, Morgan IM, Cohen RB, Lin A, Liu X…, Jalaly JB, et al Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer , JNCI: Journal of the National Cancer Institute: 2025

Hieromnimon HM, Trzcinska A, Wen FT, Howard FM, Dolezal JM, Dyer E, Kochanny S, Schulte JJ, Wang C, Chen H, Chin J, Blair E, Agrawal N, Rosenberg A, Vokes E, Katipally R, Juloori A, Izumchenko E, Lingen MW, Cipriani N, Jalaly JB, Basu D, Riesenfeld SJ, Pearson AT Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas , Oral Oncology, 163: 2025

JN Gallant, Jalaly JB, Basu Dev Molecular etiology and clinical significance of discordant HPV testing in p16+ oropharyngeal cancers , JCO: 2025

Jalaly JB MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence , The Laryngoscope: 2025

Rossi ED, Agarwal S, Erkilic S, Hang JF, Jalaly JB, Khanafshar E, Ladenheim A, Baloch Z Psammoma bodies in thyroid: are they always indicative of malignancy? A multi-institutional study , Virchows Archiv, 485: 2024

Sannigrahi, Malay K., ..., Jalaly JB, et al Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instability. , bioRxiv: 2024

View all publications